Pharmaceuticals & Health Care – Medical Technologies & Services: Third
Institutional Investor Research is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Pharmaceuticals & Health Care – Medical Technologies & Services: Third

Edward Ridley-Day & team

Bank of America Merrill Lynch

Edward Ridley-Day guides the Bank of America Merrill Lynch team of two up one notch to third place. The analysts, who work out of London, are bullish on Denmark’s Coloplast, a maker of continence, urology and wound-care devices. The company “represents one of the strongest structural growth investments in European health care, while also offering the potential of increasing cash returns to shareholders over the midterm,” says Ridley-Day. The team, which publishes research on 14 stocks, is also impressed with the company’s potential for further margin expansion from improvements in operational efficiency and material market share gains, especially in emerging economies and the U.S. The latter market is problematic for device manufacturers, however, owing to political gridlock. “We expect the reimbursement and pricing outlook to deteriorate in the U.S. for those markets exposed to government reimbursement — in particular, orthopedics, cardiovascular and capital equipment,” he says.

Leslie Kramer


Gift this article